
Characterization of antibiotic resistomes by reprogrammed bacteriophage-enabled functional metagenomics in clinical strains
- Ákos Nyerges
- Balázs Papp
- Balint Kintses
- Csaba Pál
- February 9, 2023
- kedalionlabs.com
- Gábor Apjok, Mónika Számel, Chryso Christodoulou, …, Balázs Papp, Csaba Pál, Bálint Kintses
- Nat Microbiol, 10.1038/s41564-023-01320-2
ssDNA recombineering boosts in vivo evolution of nanobodies displayed on bacterial surfaces
- Ákos Nyerges
- Csaba Pál
- October 8, 2021
- kedalionlabs.com
- Yamal Al-Ramahi, Akos Nyerges, Yago Margolles, …, Csaba Pál, Luis Ángel Fernández, Víctor de Lorenzo
- Commun Biol, 10.1038/s42003-021-02702-0
New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens
- Ákos Nyerges
- Csaba Pál
- February 1, 2021
- kedalionlabs.com
- Martina Durcik, Ákos Nyerges, Žiga Skok, …, Danijel Kikelj, Lucija Peterlin Mašič, Tihomir Tomašič
- Eur J Med Chem, 10.1016/j.ejmech.2021.113200
Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation
- Ákos Nyerges
- Csaba Pál
- December 30, 2020
- kedalionlabs.com
- Martina Durcik, Žiga Skok, Janez Ilaš, …, Csaba Pál, Lucija Peterlin Mašič, Tihomir Tomašič
- None, 10.3390/pharmaceutics13010006
Rational design of balanced dual-targeting antibiotics with limited resistance
- Ákos Nyerges
- Balint Kintses
- October 5, 2020
- kedalionlabs.com
- Akos Nyerges, Tihomir Tomašič, Martina Durcik, …, Dorota Focht, Lucija Peterlin Mašič, Csaba Pal
- PLoS Biol, 10.1371/journal.pbio.3000819